COL1A1 and metabolic dysfunction-associated steatohepatitis: The expression of inflammation (Tgf-β, Tnf-α, and Il-6) and fibrosis markers (Col1a1) were significantly upregulated by NAG-Drp1si treatment in mice with GAN-diet induced NASH (Figure 6A).